AFYX Therapeutics A/S
Latest round
- Series A
Last raised
- May 2017
Total raised
- $18M
Investors
- 3
About AFYX Therapeutics A/S
Founded in 2013, AFYX Therapeutics A/S is based in Copenhagen, Denmark, and focuses on the development of pharmaceutical solutions.' The company’s core offerings include Gefena, a Misoprostol 25µg tablet designed for the induction of labor, and Diaphine, which serves a specific therapeutic purpose in patient care. These products leverage existing technologies to tackle new medical challenges, making them relevant in various healthcare settings.9 million in the same period the previous year. This growth can be attributed to increased sales of flagship products such as Diaphine and Nimorazole, with notable demand from clients in Norway.AFYX Therapeutics plans to broaden its product offerings with new pharmaceuticals aimed at enhancing patient care, although specific upcoming products and release dates were not detailed. The company targets expansion into additional European markets to enhance its reach by 2025.00 mn will support these initiatives, facilitating research and development as well as market entry efforts. Additionally, following the acquisition by Inphena in January 2024, AFYX will leverage new resources to accelerate its growth strategy.
Who invested in AFYX Therapeutics A/S
3 investors across 1 round
See all investors in AFYX Therapeutics A/S
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 9, 2017
Amount
$18M
Investors
Questions about AFYX Therapeutics A/S
Who invested in AFYX Therapeutics A/S?
AFYX Therapeutics A/S has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AFYX Therapeutics A/S raised?
AFYX Therapeutics A/S has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AFYX Therapeutics A/S last raise money?
AFYX Therapeutics A/S's most recent round on record is a Series A, in May 2017.
What does AFYX Therapeutics A/S do?
Founded in 2013, AFYX Therapeutics A/S is based in Copenhagen, Denmark, and focuses on the development of pharmaceutical solutions.
Where is AFYX Therapeutics A/S headquartered?
AFYX Therapeutics A/S is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like AFYX Therapeutics A/S?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at AFYX Therapeutics A/S's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AFYX Therapeutics A/S? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.